These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17958783)

  • 1. Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.
    Goksugur N; Ozbostanci B; Goksugur SB
    Pediatr Dermatol; 2007; 24(5):E63-5. PubMed ID: 17958783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eczema molluscatum in tacrolimus treated atopic dermatitis.
    Wetzel S; Wollenberg A
    Eur J Dermatol; 2004; 14(1):73-4. PubMed ID: 14965804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba.
    Fujita WH; McCormick CL; Parneix-Spake A
    Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment.
    Wilson LM; Reid CM
    Australas J Dermatol; 2004 Aug; 45(3):184-5. PubMed ID: 15250900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema.
    Meurer M; Lubbe J; Kapp A; Schneider D
    Dermatology; 2007; 215 Suppl 1():18-26. PubMed ID: 18174690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
    Bos JD
    Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
    Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus.
    Lerbaek A; Agner T
    Br J Dermatol; 2004 Jun; 150(6):1210-1. PubMed ID: 15214914
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
    Werfel T
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
    Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
    Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.
    Langley RG; Luger TA; Cork MJ; Schneider D; Paul C
    Dermatology; 2007; 215 Suppl 1():27-44. PubMed ID: 18174691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K
    Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream.
    Segura S; Romero D; Carrera C; Iranzo P; Estrach T
    Acta Derm Venereol; 2005; 85(6):524-5. PubMed ID: 16396803
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children.
    Netchiporouk E; Cohen BA
    Pediatrics; 2012 Apr; 129(4):e1072-5. PubMed ID: 22412023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.